A new study reveals that, among patients of advanced age with stage III lung cancer, African Americans and individuals who live in lower income areas are more likely to not receive any treatment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also found that patients who receive the standard of care treatment for their cancer live longer.
Individuals in their 80s and 90s may not receive standard of care therapy for lung cancer due to their age and concerns about fragility. To gain insights on how octogenarian and nonagenarian patients are treated and how they fare, Richard Cassidy, MD, of the Winship Cancer Institute of Emory University, and his colleagues examined information on U.S. patients aged 80 years and older with stage III non-small cell lung cancer from 2004-2013 who had complete treatment records available in the National Cancer Data Base.
Among 12,641 patients, 7921 (62.7 percent) received no therapy. Black race and living in a lower-educated census-tract were linked with a 23 percent and 20 percent increased likelihood of not receiving care, respectively, while treatment at an academic center was associated with a 20 percent increased likelihood of receiving cancer-directed therapy. Patients who received no treatment or only radiation were more likely to die during the years analyzed than those receiving concurrent chemotherapy and radiation, the standard of care for stage III non-small cell lung cancer.
"Our study is the largest to look at patients 80 years and older with stage III lung cancer. We highlight risks for patients not receiving standard therapy and show that patients who receive standard care live longer," said Dr. Cassidy. "Our study also highlights healthcare disparities in the oncology community and showcases a need for the oncology community to address. This may provide information to guide outreach programs to engage the elderly community in seeking appropriate therapy for stage III lung cancer."
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:
Dawn Peters (US) +1 781-388-8408
Follow us on Twitter @WileyNews
Full Citation: "Healthcare disparities among octogenarians and nonagenarians with stage III lung cancer." Richard J. Cassidy, Xinyan Zhang, Jeffrey M. Switchenko, Pretesh R. Patel, Joseph W. Shelton, Sibo Tian, Ronica H. Nanda, Conor E. Steuer, Rathi N. Pillai, Taofeek K. Owonikoko, Suresh S. Ramalingam, Felix G. Fernandez, Seth D. Force, Theresa W. Gillespie, Walter J. Curran, and Kristin A. Higgins. CANCER; Published Online: January 8, 2018 (DOI: 10.1002/cncr.31077).
URL Upon Publication: http://doi.
Author Contact: Judy Fortin-Lalone, of the Winship Cancer Institute's communications office, at email@example.com.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.
Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.